- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Event – Agitation Associated With Alzheimer’s Dementia Disease State Education: Clinical, Humanistic & Economic Burden

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Agitation Associated With Alzheimer’s Dementia Disease State Education: Clinical, Humanistic & Economic Burden
This is a Virtual Event for PsychU Members in Delaware, Maryland, New Jersey, Pennsylvania, and West Virginia.
In this presentation, topics of discussion are:
- Clinical burden
- Humanistic burden
- Economic burden
- AAD is associated with substantial patient burden and long-term consequences

E. Jeffrey Greenberg, MD
Neurologist at Princeton & Rutgers Neurology, P.A., Co-Founder of Advanced Clinical Institute
More

Becky Wong, PharmD, MBA
Medical Science Director
Speaker E. Jeffrey Greenberg, MD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Speaker Becky Wong, PharmD, MBA is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)